Portrait of Crenshaw, Daniel

Crenshaw, Daniel

U.S. Representative TX-2 Republican Party

Congressional stock trade history disclosed under the STOCK Act, parsed and scored by FilingIQ.

Disclosed trades
33
Buys / sells
64% / 36%
Last trade
Mar 20, 2023
Last filing
Apr 20, 2023

Latest disclosed trades

Latest 10 of 33
Ticker Type Traded
SPY Buy Mar 20, 2023
META Buy Oct 25, 2022
AAPL Buy Oct 25, 2022
WYNN Buy Oct 25, 2022
GOOG Buy Oct 25, 2022
FAS Buy Oct 25, 2022
AMZN Buy Oct 25, 2022
USO Buy Oct 25, 2022
SPY Sell Jan 26, 2022
LUV Sell Jan 20, 2022

Amounts are reported as STOCK Act range buckets, not exact dollar values. Trade dates are the date the politician executed the trade; filing dates are when the disclosure was filed. Sign up to filter by ticker, amount range, or filing window, and to see the FilingIQ Score on every trade.

Crenshaw, Daniel stock trade activity

FilingIQ has indexed 33 congressional stock trade disclosures for Crenshaw, Daniel. The most recent disclosed transaction is dated Mar 20, 2023.

Across the full history, 21 purchases and 12 sales have been disclosed under the STOCK Act.

Top tickers traded by Crenshaw, Daniel

Frequently asked

How many stock trades has Crenshaw, Daniel disclosed?
FilingIQ tracks 33 Periodic Transaction Report disclosures for Crenshaw, Daniel, with the most recent dated Mar 20, 2023. Every entry sources back to the official House Office of the Clerk or Senate Office of Public Records.
Is Crenshaw, Daniel a net buyer or net seller?
Across the disclosed trade history, 21 (64%) were purchases and 12 (36%) were sales. Compensation and exchanges are filtered out of these counts.
Where does FilingIQ's data on Crenshaw, Daniel come from?
Every trade shown on this page is sourced from the STOCK Act disclosures filed with the House or Senate. FilingIQ normalizes ticker resolution, dates, and amount brackets across both chambers.

Methodology & sources

Disclosures parsed from official House Office of the Clerk and Senate Office of Public Records filings. Methodology documented on methodology. Compiled by Thomas Kraaibeek. Not investment advice; see disclaimer.